National Study Identifies Liver Disease as Fourth Major Diabetes Complication
A groundbreaking national study has uncovered that a large number of diabetics in Gujarat, often called India's diabetes capital, could be silently living with undiagnosed liver damage. Published in The Lancet Regional Health – Southeast Asia in April 2026, the research now identifies liver disease as the "fourth major complication" of diabetes, alongside traditional issues affecting the eyes, kidneys, and nerves.
Alarming Findings on Liver Damage Among Diabetics
The study, known as the DiaFib-Liver Study, analyzed over 9,000 patients across India at 27 hospitals and clinics, including prominent centers like Sir Ganga Ram Hospital in Delhi, Medanta in Gurugram, PGIMER in Chandigarh, and the Madras Diabetes Research Foundation in Chennai. Contributions also came from Gujarat-based centers in Vadodara, Ahmedabad, and Himmatnagar. Key findings include:
- 26% of patients had clinically significant fibrosis.
- 14% showed advanced fibrosis.
- 5% met thresholds consistent with cirrhosis.
Most concerning is that the majority of these patients were asymptomatic and not under the care of liver specialists, indicating a hidden epidemic of advanced liver disease.
Liver Damage Extends Beyond Fatty Liver Cases
What makes these results particularly worrying is that liver damage was not limited to those with fatty liver. Nearly 13% of patients without detectable liver fat still exhibited fibrosis, including 4% in the cirrhosis range. This suggests that current screening approaches may be missing high-risk individuals, potentially changing how diabetes is managed.
Experts emphasize that until now, routine diabetes care has largely focused on complications affecting the eyes, nerves, and kidneys. However, doctors now assert that the liver requires equal attention, especially in high-burden states like Gujarat.
Expert Insights and Call for Action
Dr. Parag Rana, a Vadodara-based diabetologist and contributor to the study, stated, "This is a significant shift in our understanding of diabetes complications. Liver disease is emerging as a parallel and often silent threat, and many patients may already have advanced damage without knowing it." He added, "There is a clear need to integrate liver fibrosis screening into routine diabetes care so that cases can be detected early."
The study also identified key risk factors linked to liver fibrosis, including:
- Obesity
- High cholesterol
- Long-standing diabetes
- Reduced kidney function
Conducted over seven months in community clinics, the research excluded patients already undergoing liver treatment, making it reflective of real-world conditions.
Gujarat's Specific Challenges and Health Implications
For Gujarat, the warning is clear: a silent liver disease epidemic may already be unfolding among diabetics, risking going unnoticed without urgent changes in screening practices. Dr. Niraj Chawda, MD (Medicine), explained, "Diabetes is essentially a metabolic disorder driven by insulin resistance. Since insulin is a fat-storage hormone, it leads to fat accumulation in multiple organs, especially the liver. The problem is that liver damage is silent—there is no pain or early warning—so most patients ignore it until the disease has already advanced."
He further highlighted regional factors, noting, "In Gujarat, where diets are typically high in carbohydrates and fats but low in protein, and junk food consumption is rising even among children, we are seeing increasing cases of fatty liver. If not addressed early, this can progress to inflammation, fibrosis, and even cirrhosis."
This study underscores the critical need for enhanced screening and management strategies to combat this emerging health threat in diabetes care.
